Blog

Drug Price Legislation Faces Challenges

By Donna White | July 17, 2019
Category

In May we released an article about a proposed rule coming down from CMS regarding drug prices in advertising. In […]

Executive Order Reduces HHS Time for Transparency

By Donna White | June 26, 2019
Category

An executive order issued this week calls for the U.S. Department of Health and Human Services (HHS) to write the […]

Drugmakers Sue Over Drug Prices in Ads

By Donna White | June 19, 2019
Category

Pharmaceutical companies like Amgen Inc, Merk & Co, Eli Lilly and Co, as well as the Association of National Advertisers,  […]

Only 20% of Hospitals meet Maternity Care Performance Standards

By Donna White | May 30, 2019
Category

Alarmingly, based on a 2017 study, the U.S. has the worst rate of maternal deaths in the developed world. Let […]

CMS Final Rule for Drug Prices in Advertising

By Donna White | May 8, 2019
Category

A rule proposed in October of last year has become final on May 8, 2019. This rule would mandate that […]

Data in Today’s Healthcare Market

By Donna White | April 24, 2019
Category

Since the introduction of the HITECH Act, there has been a fast-paced shift to incorporate technology into healthcare. With a […]

Telemedicine and Increased Antibiotics Prescriptions for Kids

By Donna White | April 10, 2019
Category

We have been reviewing telemedicine a lot lately. Telemedicine is still in its infancy, with many providers hesitant to jump […]

Congress Tackles Surprise Medical Bills

By Donna White | April 4, 2019
Category

In a rare bi-partisan effort this week, the House Health, Employment, Labor and Pensions subcommittee heard testimony regarding what can […]

Telehealth Utilization by Patients on the Rise

By Donna White | March 27, 2019
Category

Stanford Children’s Health in Palo Alto, CA has grown their telehealth program exponentially over the last three years. Their goal […]